CBD Disrupted Both Specific and Generalized Fear Memories Through Cannabinoid Receptors in the Hippocampus
CBD given immediately after fear learning disrupted both specific fear memories and fear generalization in rats, working through anandamide-mediated activation of both CB1 and CB2 receptors in the dorsal hippocampus.
Quick Facts
What This Study Found
Researchers induced different intensities of fear memories in rats using varying shock levels, creating either specific fear (responding only to the original context) or generalized fear (responding fearfully to new, similar contexts).
CBD (3-30 mg/kg) given immediately after fear acquisition disrupted consolidation of both types. For specific fear, it reduced conditioned freezing. For generalized fear, it reduced fear generalization, stress-related ultrasonic vocalizations (22 kHz calls), and resistance to extinction. CBD had no effect on short-term memory, and delayed treatment (not immediately after acquisition) was ineffective.
Mechanistically, both CB1 receptor blockade (AM251) and CB2 receptor blockade (AM630) prevented CBD's memory-disrupting effects, whether the antagonists were given systemically or directly into the dorsal hippocampus. The FAAH inhibitor URB597 (which boosts anandamide) replicated CBD's effects, suggesting CBD works indirectly through anandamide signaling.
Key Numbers
CBD doses: 3-30 mg/kg. Effective only when given immediately after acquisition (not delayed). Both AM251 (CB1 antagonist) and AM630 (CB2 antagonist) blocked CBD effects. FAAH inhibitor URB597 replicated CBD effects. Dorsal hippocampus confirmed as the critical brain region.
How They Did This
Contextual fear conditioning in rats with varying shock intensities. CBD or vehicle was given immediately or delayed after conditioning. Memory was tested 24 hours later. Pharmacological antagonists identified receptor involvement. Intra-hippocampal microinjections localized effects to the dorsal hippocampus.
Why This Research Matters
Fear generalization, where fear extends beyond the original traumatic context to everyday situations, is a hallmark of PTSD. This study shows CBD can disrupt not just specific fear memories but also this pathological generalization process. The involvement of both CB1 and CB2 receptors in the hippocampus provides mechanistic targets for future therapeutic development.
The Bigger Picture
This study adds to the growing evidence that CBD could have therapeutic value for trauma-related disorders. The finding that CBD works through anandamide-mediated signaling at both CB1 and CB2 receptors provides a more complete mechanistic picture than previous studies and identifies the dorsal hippocampus as a key site of action.
What This Study Doesn't Tell Us
Animal study using injection routes not feasible in humans. The fear conditioning paradigm is a simplified model of trauma. CBD was effective only when given immediately after fear acquisition, which may not translate to treating established traumatic memories. The involvement of two receptor types complicates potential pharmaceutical development.
Questions This Raises
- ?Could CBD disrupt already-consolidated traumatic memories during reconsolidation?
- ?Would systemic CBD reach the hippocampus at sufficient concentrations to replicate these effects?
- ?Is the timing window for CBD's effects on fear consolidation feasible for clinical PTSD prevention?
Trust & Context
- Key Stat:
- CBD disrupted fear generalization, a hallmark of PTSD, through both CB1 and CB2 hippocampal receptors
- Evidence Grade:
- Preliminary evidence from a well-designed animal study with strong mechanistic dissection.
- Study Age:
- Published in 2017. Preclinical research supporting CBD's potential for fear-related disorders.
- Original Title:
- Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.
- Published In:
- Neuropharmacology, 125, 220-230 (2017)
- Authors:
- Stern, Cristina A J(4), da Silva, Thiago R(2), Raymundi, Ana M, de Souza, Camila P, Hiroaki-Sato, Vinicius A, Kato, Luiza, Guimarães, Francisco S, Andreatini, Roberto, Takahashi, Reinaldo N, Bertoglio, Leandro J
- Database ID:
- RTHC-01529
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Could CBD prevent PTSD if taken right after a traumatic event?
This animal study found CBD disrupted fear memory consolidation when given immediately after fear learning. In theory, this could apply to preventing PTSD after trauma, but the study used injection in rats, not oral CBD in humans. Clinical trials would be needed to test this application, and the timing window (immediately after trauma) poses practical challenges.
What is fear generalization and why does it matter?
Fear generalization is when fear extends beyond the original threatening situation to similar but safe contexts. In PTSD, this causes people to feel afraid in everyday situations that resemble the trauma. This study showed CBD specifically reduced fear generalization, suggesting it could address one of the most debilitating aspects of trauma-related disorders.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-01529APA
Stern, Cristina A J; da Silva, Thiago R; Raymundi, Ana M; de Souza, Camila P; Hiroaki-Sato, Vinicius A; Kato, Luiza; Guimarães, Francisco S; Andreatini, Roberto; Takahashi, Reinaldo N; Bertoglio, Leandro J. (2017). Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.. Neuropharmacology, 125, 220-230. https://doi.org/10.1016/j.neuropharm.2017.07.024
MLA
Stern, Cristina A J, et al. "Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors.." Neuropharmacology, 2017. https://doi.org/10.1016/j.neuropharm.2017.07.024
RethinkTHC
RethinkTHC Research Database. "Cannabidiol disrupts the consolidation of specific and gener..." RTHC-01529. Retrieved from https://rethinkthc.com/research/stern-2017-cannabidiol-disrupts-the-consolidation
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.